4512 — Wakamoto Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Wakamoto Pharmaceutical, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 285 | 212 | 159 | 7.46 | 256 |
| Depreciation | |||||
| Non-Cash Items | -223 | 14.4 | -478 | -524 | 229 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -193 | -39.8 | -200 | -506 | -1,416 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 339 | 632 | -107 | -592 | -487 |
| Capital Expenditures | -303 | -163 | -556 | -476 | -616 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 353 | 180 | 553 | 462 | -41.8 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 50.6 | 17.1 | -2.35 | -13.5 | -658 |
| Financing Cash Flow Items | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.62 | -1.61 | -105 | -104 | 196 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 388 | 647 | -215 | -710 | -949 |